BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24377580)

  • 1. Analysis of radiofrequency ablation of small renal tumors in patients at high anesthetic and surgical risk: urologist experience with follow-up results in the initial six months.
    Yuksel MB; Karakose A; Gumus B; Tarhan S; Atesci YZ; Akan Z
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6637-41. PubMed ID: 24377580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
    Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation of renal tumors: four-year follow-up results in 47 patients.
    Kim SD; Yoon SG; Sung GT
    Korean J Radiol; 2012; 13(5):625-33. PubMed ID: 22977331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
    Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
    Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantages of Laparoscopic Radiofrequency Ablation Over Percutaneous Radiofrequency Ablation in Hepatocellular Carcinoma.
    Eun HS; Lee BS; Kwon IS; Yun GY; Lee ES; Joo JS; Sung JK; Moon HS; Kang SH; Kim JS; Shin HJ; Kim TK; Chun K; Kim SH
    Dig Dis Sci; 2017 Sep; 62(9):2586-2600. PubMed ID: 28744835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of renal masses with laparoscopic-guided radiofrequency ablation versus laparoscopic partial nephrectomy.
    Bird VG; Carey RI; Ayyathurai R; Bird VY
    J Endourol; 2009 Jan; 23(1):81-8. PubMed ID: 19118475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes.
    Yang R; Lian H; Zhang G; Wang W; Gan W; Li X; Yan X; Zhang S; Zhao X; Guo H
    J Endourol; 2014 Jan; 28(1):4-9. PubMed ID: 23998802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of contrast-enhanced ultrasound after percutaneous renal tumor ablation.
    Guo F; Hu B; Chen L; Li J
    Br J Radiol; 2019 Nov; 92(1103):20190183. PubMed ID: 31509441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal tumors: technical success and early clinical experience with radiofrequency ablation of 18 tumors.
    Sabharwal R; Vladica P
    Cardiovasc Intervent Radiol; 2006; 29(2):202-9. PubMed ID: 16447001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic outcomes using real-time peripheral thermometry-guided radiofrequency ablation of small renal masses.
    Leveillee RJ; Castle SM; Gorbatiy V; Salas N; Narayanan G; Morillo-Burgos G; Jorda M; Faraday MM
    J Endourol; 2013 Apr; 27(4):480-9. PubMed ID: 23098088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
    Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-center comparison of complications in laparoscopic and percutaneous radiofrequency ablation with ultrasound guidance for renal tumors.
    Lian H; Guo H; Zhang G; Yang R; Gan W; Li X; Ji C; Liu J
    Urology; 2012 Jul; 80(1):119-24. PubMed ID: 22633890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation of renal tumors in the solitary kidney.
    Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
    Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results.
    Su Li; Jarrett TW; Chan DY; Kavoussi LR; Solomon SB
    Urology; 2003 Apr; 61(4 Suppl 1):26-33. PubMed ID: 12657358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors.
    Ferakis N; Bouropoulos C; Granitsas T; Mylona S; Poulias I
    J Endourol; 2010 Dec; 24(12):1909-13. PubMed ID: 20946062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
    Kim HJ; Park BK; Park JJ; Kim CK
    Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
    Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
    Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.